Stereotaxis Launches the e-Contact™ Module in Europe
Jun 15, 2017 13:00 pm UTC| Business
ST. LOUIS, June 15, 2017 -- Stereotaxis, Inc. (OTCQX:STXS), a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the European launch of the e-Contact™ module. The...
Host Hotels & Resorts, Inc. Announces Second Quarter Dividend on Common Stock
Jun 15, 2017 12:55 pm UTC| Business
BETHESDA, Md., June 15, 2017 -- Host Hotels Resorts, Inc. (NYSE:HST) (the “Company”), the nation’s largest lodging real estate investment trust, today announced that its board of directors authorized a regular...
Oxford Declares Quarterly Cash Dividend
Jun 15, 2017 12:45 pm UTC| Business
ATLANTA, June 15, 2017 -- Oxford Industries, Inc. (NYSE:OXM) announced today that on June 14, 2017 its Board of Directors declared a cash dividend of $0.27 per share on common stock. The dividend is payable on July 28,...
Yield10 Bioscience Submits “Am I Regulated?” Letter to USDA-APHIS BRS for Genome-Edited Camelina
Jun 15, 2017 12:45 pm UTC| Business
WOBURN, Mass., June 15, 2017 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it has submitted an “Am I Regulated?” letter to USDA-APHIS’s Biotechnology Regulatory Services (BRS) to confirm that its...
Jun 15, 2017 12:30 pm UTC| Business
CHATSWORTH, Calif., June 15, 2017 -- Capstone Turbine Corporation (www.capstoneturbine.com) (NASDAQ:CPST), the world's leading clean technology manufacturer of microturbine energy systems, announced today that its Chief...
Jun 15, 2017 12:30 pm UTC| Business
- Iomab-B Phase 3 SIERRA trial enrollment is accelerating as the number of clinical trial sites increase, competitive position as only induction and conditioning regimen remains unchallenged - Actimab-A Phase 2 trial...
Jun 15, 2017 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., June 15, 2017 -- Portola Pharmaceuticals Inc.® (Nasdaq:PTLA) today announced the presentation of interim data from a Phase 2a study evaluating cerdulatinib in patients with...